The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
This predictive technology empowers people with diabetes to take preventive action before complications arise
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Strengthening capabilities in Peptide Therapeutics and CDMO services
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Subscribe To Our Newsletter & Stay Updated
